Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 5Breast 3Sarcoma 2Gynecologic 2Genitourinary 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1CNS 1

Conditions

Breast Neoplasms 2Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
High-Throughput Nucleotide Sequencing × Breast × Clear all
NCT04261972 2026-01-14

CHARM1

University Health Network, Toronto

Active not recruiting
1,416 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasms, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT05763472 2023-03-10

Gen-eva

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Unknown
10 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT04996836 2021-08-13

BR(E)2ASTOME

University of Campania Luigi Vanvitelli

Phase 2 Unknown
200 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡